Correlation Between Alto Neuroscience, and Cardiff Oncology

Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alto Neuroscience, and Cardiff Oncology, you can compare the effects of market volatilities on Alto Neuroscience, and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Cardiff Oncology.

Diversification Opportunities for Alto Neuroscience, and Cardiff Oncology

-0.37

Correlation Coefficient

Alto Neuroscience,  Cardiff Oncology

Very good diversification

The 3 months correlation between Alto and Cardiff is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Cardiff Oncology go up and down completely randomly.

Pair Corralation between Alto Neuroscience, and Cardiff Oncology

Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Cardiff Oncology. In addition to that, Alto Neuroscience, is 1.04 times more volatile than Cardiff Oncology. It trades about -0.04 of its total potential returns per unit of risk. Cardiff Oncology is currently generating about 0.05 per unit of volatility. If you would invest  175.00  in Cardiff Oncology on September 14, 2024 and sell it today you would earn a total of  152.00  from holding Cardiff Oncology or generate 86.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	55.73%
Values	Daily Returns

Alto Neuroscience,  vs.  Cardiff Oncology

Alto Neuroscience,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alto Neuroscience, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cardiff Oncology

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alto Neuroscience, and Cardiff Oncology

The main advantage of trading using opposite Alto Neuroscience, and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.

The idea behind Alto Neuroscience, and Cardiff Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.